FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Tötterman

Research Profile

Anatomy

Physiology

Lymphocyte Activation

Procedures

Flow Cytometry

Disorders

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Arian Sadeghi; Thomas H Tötterman; Gustav J Ullenhag; Gunnar Wagenius; Fredrik Eriksson
Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery.
A K Lidehäll; G Malm; Fredrik Sund; Thomas H Tötterman; U Ewald; E Karltorp; Olle Korsgren; Ilona Lewensohn-Fuchs; Mona-Lisa Engman; Britt-Marie Eriksson
Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
Gustav J Ullenhag; Gunnar Wagenius; Håkan Ahlström; Björn Carlsson; Firas Mosavi; Arian M Sadeghi; Thomas H Tötterman
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Tötterman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Arian Sadeghi; Thomas H Tötterman; Gustav J Ullenhag; Gunnar Wagenius; Fredrik Eriksson
Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery.
Acta oncologica (Stockholm, Sweden) 2013;52(5):978-86.
2013: A K Lidehäll; G Malm; Fredrik Sund; Thomas H Tötterman; U Ewald; E Karltorp; Olle Korsgren; Ilona Lewensohn-Fuchs; Mona-Lisa Engman; Britt-Marie Eriksson
Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.
Scandinavian journal of immunology 2013;77(2):135-43.
2012: Gustav J Ullenhag; Gunnar Wagenius; Håkan Ahlström; Björn Carlsson; Firas Mosavi; Arian M Sadeghi; Thomas H Tötterman
Adoptive T-cell therapy for malignant melanoma patients with TILs obtained by ultrasound-guided needle biopsy.
Cancer immunology, immunotherapy : CII 2012;61(5):725-32.
2011: Camilla A Lindqvist; Lisa H Christiansson; Gunilla Enblad; Per Frisk; Sara Mangsbo; Ulla Olsson-Strömberg; Gabriella Paul-Wetterberg; Bengt Simonsson; Christer Sundström; Ingrid Thörn; Thomas H Tötterman; Angelica Loskog
Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.
Immunology 2011;133(3):296-306.
2011: Arian Sadeghi; Linnea Pauler; Cecilia Annerén; Andrew Friberg; Daniel Brandhorst; Olle Korsgren; Thomas H Tötterman
Large-scale bioreactor expansion of tumor-infiltrating lymphocytes.
Journal of immunological methods 2011;364(1-2):94-100.
2010: A Danielsson; Graciela Elgue; B M Nilsson; Bo Nilsson; John D Lambris; Thomas H Tötterman; S Kochanek; F Kreppel; Magnus Essand
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood.
Gene therapy 2010;17(6):752-62.
2010: Fredrik Sund; Anna-Karin Lidehäll; Kerstin Claesson; Aksel Foss; Thomas H Tötterman; Olle Korsgren; Britt-Marie Eriksson
CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
Clinical transplantation 2010;24(3):401-9.
2010: Sara Mangsbo; Linda C Sandin; Kerstin Anger; Alan J Korman; Angelica Loskog; Thomas H Tötterman
Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(3):225-35.
2009: Sara Mangsbo; Javier Sanchez; Kerstin Anger; John D Lambris; Kristina Nilsson Ekdahl; Angelica Loskog; Bo Nilsson; Thomas H Tötterman
Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(10):6724-32.
2009: Justyna Leja; Ahmed Essaghir; Magnus Essand; Kenneth Wester; Kjell Oberg; Thomas H Tötterman; Ricardo Lloyd; George Vasmatzis; Jean-Baptiste Demoulin; Valeria Giandomenico
Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(2):261-72.
2009: Ole Forsberg; Björn Carlsson; Per-Uno Malmstrom; Gustav Ullenhag; Thomas H Tötterman; Magnus Essand
High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
The Prostate 2009;69(1):70-81.
2009: Moa E Fransson; Lina S E Liljenfeldt; Jan Fagius; Thomas H Tötterman; Angelica S I Loskog
The T-cell pool is anergized in patients with multiple sclerosis in remission.
Immunology 2009;126(1):92-101.
2008: Björn Carlsson; Arian Sadeghi; Mats Bengtsson; Gunnar Wagenius; Thomas H Tötterman
Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(7):633-43.
2008: Henrik von Euler; Arian Sadeghi; Björn Carlsson; Patricio Rivera; Angelica Loskog; T Segall; Olle Korsgren; Thomas H Tötterman
Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(4):377-84.
2008: Ole Forsberg; Björn Carlsson; Thomas H Tötterman; Magnus Essand
Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
British journal of haematology 2008;141(2):188-99.
2008: Sofia Vikman; Valeria Giandomenico; Roberta Sommaggio; Kjell Oberg; Magnus Essand; Thomas H Tötterman
CD8+ T cells against multiple tumor-associated antigens in peripheral blood of midgut carcinoid patients.
Cancer immunology, immunotherapy : CII 2008;57(3):399-409.
2008: Sara Mangsbo; Christina Ninalga; Magnus Essand; Angelica Loskog; Thomas H Tötterman
CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):34-42.
2007: Angelica Loskog; Thomas H Tötterman
CD40L - a multipotent molecule for tumor therapy.
Endocrine, metabolic & immune disorders drug targets 2007;7(1):23-8.
2007: Björn Carlsson; Ole Forsberg; Mats Bengtsson; Thomas H Tötterman; Magnus Essand
Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy.
The Prostate 2007;67(4):389-95.
2007: Angelica Loskog; Christina Ninalga; Gabriella Paul-Wetterberg; Manuel de la Torre; Per-Uno Malmstrom; Thomas H Tötterman
Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines.
The Journal of urology 2007;177(1):353-8.
2006: Helena Dzojic; Angelica Loskog; Thomas H Tötterman; Magnus Essand
Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.
The Prostate 2006;66(8):831-8.
2006: Angelica Loskog; Christina Ninalga; Thomas H Tötterman
Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors.
Cancer immunology, immunotherapy : CII 2006;55(5):588-97.
2006: Wing-Shing Cheng; Helena Dzojic; Berith Nilsson; Thomas H Tötterman; Magnus Essand
An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer.
Cancer gene therapy 2006;13(1):13-20.
2005: Angelica Loskog; Christina Ninalga; T Hedlund; M Alimohammadi; Per-Uno Malmstrom; Thomas H Tötterman
Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.
Laboratory animals 2005;39(4):384-93.
2005: Anna K Lidehall; Fredrik Sund; Tobias Lundberg; Britt-Marie Eriksson; Thomas H Tötterman; Olle Korsgren
T cell control of primary and latent cytomegalovirus infections in healthy subjects.
Journal of clinical immunology 2005;25(5):473-81.
2005: Sofia Vikman; Magnus Essand; Janet L Cunningham; Manuel de la Torre; Kjell Oberg; Thomas H Tötterman; Valeria Giandomenico
Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
Acta oncologica (Stockholm, Sweden) 2005;44(1):32-40.
2005: Christina Ninalga; Angelica Loskog; Magdalena Klevenfeldt; Magnus Essand; Thomas H Tötterman
CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(1):20-7.
2004: I A F M Heijnen; David Barnett; Maria J Arroz; Simon M Barry; Marc Bonneville; Bruno Brando; Jean-Luc D'Hautcourt; Florian Kern; Thomas H Tötterman; Erik W A Marijt; David Bossy; Frank W M B Preijers; Gregor Rothe; Jan W Gratama
Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation.
Cytometry. Part B, Clinical cytometry 2004;62(1):1-13.
2004: Björn Carlsson; Thomas H Tötterman; Magnus Essand
Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP.
The Prostate 2004;61(2):161-70.
2004: Wing-Shing Cheng; Robert Kraaij; Berith Nilsson; Laura van der Weel; Corrina M A de Ridder; Thomas H Tötterman; Magnus Essand
A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(2):355-64.
2003: Björn Carlsson; Wing-Shing Cheng; Thomas H Tötterman; Magnus Essand
Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators.
British journal of haematology 2003;121(3):428-38.
2002: Angelica Loskog; Thomas H Tötterman; Andreas Böhle; Sven Brandau
In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Cancer gene therapy 2002;9(10):846-53.
2002: Angelica Loskog; T Hedlund; Kenneth Wester; Manuel de la Torre; L Philipson; Per-Uno Malmstrom; Thomas H Tötterman
Human urinary bladder carcinomas express adenovirus attachment and internalization receptors.
Gene therapy 2002;9(9):547-53.
2001: L Ragnarsson; Thomas Strömberg; J Wijdenes; Thomas H Tötterman; C Weigelt
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells.
Cancer immunology, immunotherapy : CII 2001;50(7):382-90.
2001: Angelica Loskog; A Björkland; M P Brown; Olle Korsgren; Per-Uno Malmstrom; Thomas H Tötterman
Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer.
The Journal of urology 2001;166(3):1093-7.
2001: Britt-Marie Eriksson; Jan Sjölin; K Claesson; Benita Zweygberg Wirgart; Lena Grillner; Thomas H Tötterman
Circulating soluble vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in immunocompetent and renal transplant patients: correlation with cytomegalovirus disease and renal function.
Scandinavian journal of infectious diseases 2001;33(5):350-4.
2000: Mats Engstrand; C Tournay; Marie-Alix Peyrat; Britt-Marie Eriksson; Jonas Wadström; Benita Zweygberg Wirgart; François Romagné; Marc Bonneville; Thomas H Tötterman; Olle Korsgren
Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants.
Transplantation 2000;69(11):2243-50.
1999: Ola Söderberg; Ulf Thunberg; C Weigelt; I Christiansen; Thomas H Tötterman; M Carlsson; Jan Sällström; Kenneth Nilsson
Staphylococcus aureus Cowan strain 1 activation of B-chronic lymphocytic leukaemia cells augments the response to CD40 stimulation.
Scandinavian journal of immunology 1999;50(4):363-70.
1999: I Christiansen; Christer Sundström; Karl Mikael Kälkner; J Bring; Thomas H Tötterman
Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
European journal of haematology 1999;62(3):202-9.
1998: I Christiansen; Christer Sundström; Thomas H Tötterman
Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia.
British journal of haematology 1998;103(4):1129-37.
1998: I Christiansen; Christer Sundström; Karl Mikael Kälkner; J Bring; Thomas H Tötterman
Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
European journal of haematology 1998;61(5):311-8.
1998: I Christiansen; Christer Sundström; G Enblad; Thomas H Tötterman
Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
British journal of haematology 1998;102(3):701-9.
1998: Ulf Thunberg; C Gidlöf; M Bånghagen; Jan Sällström; Christer Sundström; Thomas H Tötterman
HpaII polymerase chain reaction restriction fragment length polymorphism in the human CD19 gene on 16p11.
Human heredity 1998;48(4):230-1.
1998: C Gidlöf; B Carlson; M Dohlsten; Thomas H Tötterman
Antibody-directed superantigen-mediated T-cell killing of myeloid leukaemic cell line cells.
European journal of haematology 1998;60(4):233-9.
1998: Thomas H Tötterman; C Gidlöf; L Ragnarsson; E Högbom; M Lindeberg; N von der Lehr; A Einarsson; M Soegaard; K Kristensson; T Kalland; M Dohlsten
Targeted superantigens for immunotherapy of haematopoietic tumours.
Vox sanguinis 1998;74 Suppl 2():483-7.
1997: M R Huang; M Olsson; A Kallin; U Pettersson; Thomas H Tötterman
Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells.
Gene therapy 1997;4(10):1093-9.
1997: S Josephson; P Lind; Thomas H Tötterman
[Protein drugs can be designed now. Targeting and cancer destroying drugs soon available].
Läkartidningen 1997;94(30-31):2650-3.
1997: A Nishio; Judith A van de Water; Patrick S C Leung; Ruth E Joplin; James M Neuberger; J Lake; A Björkland; Thomas H Tötterman; M Peters; Howard J Worman; Aftab A Ansari; Ross Coppel; M Eric Gershwin
Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1997;25(5):1085-9.
1997: C Gidlöf; M Dohlsten; PA Lando; T Kalland; Christer Sundström; Thomas H Tötterman
A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Blood 1997;89(6):2089-97.
1996: Mattias Höglund; B Smedmyr; Bengt Simonsson; Thomas H Tötterman; M Bengtsson
Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.
Bone marrow transplantation 1996;18(1):19-27.
1995: C Gidlöf; M Dohlsten; T Kalland; Thomas H Tötterman
Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
Leukemia 1995;9(9):1534-42.
1994: R Festin; A Björkland; Thomas H Tötterman
Multicolor flow cytometric analysis of the CD45 antigen provides improved lymphoid cell discrimination in bone marrow and tissue biopsies.
Journal of immunological methods 1994;177(1-2):215-24.
1994: I Christiansen; C Gidlöf; A C Wallgren; B Simonsson; Thomas H Tötterman
Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Blood 1994;84(9):3010-6.
1994: A Björkland; L Lööf; I Mendel-Hartvig; Thomas H Tötterman
Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2750-7.
1994: B Gudbjörnsson; Roger Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; Thomas H Tötterman
Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.
Annals of the rheumatic diseases 1994;53(9):574-9.
1994: G Gannedahl; A Karlsson-Parra; A Wallgren; E Roos-Engstrand; B Nilsson; Thomas H Tötterman; Gunnar Tufveson
Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
Transplantation 1994;58(3):337-44.
1994: NG Arvidson; B Gudbjörnsson; L Elfman; A C Rydén; Thomas H Tötterman; Roger Hällgren
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.
Annals of the rheumatic diseases 1994;53(8):521-4.
1994: A Björkland; Thomas H Tötterman
Is primary biliary cirrhosis an autoimmune disease?
Scandinavian journal of gastroenterology. Supplement 1994;204():32-9.
1993: A Wallgren; R Festin; C Gidlöf; M Dohlsten; T Kalland; Thomas H Tötterman
Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
Blood 1993;82(4):1230-8.
1993: G Gannedahl; A Karlsson-Parra; Thomas H Tötterman; Gunnar Tufveson
15-Deoxyspergualin inhibits antibody production in mouse to rat heart transplantation.
Transplantation proceedings 1993;25(1 Pt 1):778-80.
1992: G Gannedahl; A Karlsson-Parra; Thomas H Tötterman; Gunnar Tufveson
15-Deoxyspergualin and mouse to rat heart retransplantation.
Transplantation proceedings 1992;24(2):710-1.
1992: G Gannedahl; A Karlsson-Parra; Thomas H Tötterman; Gunnar Tufveson
Retransplantation after heart xenografting.
Transplantation proceedings 1992;24(2):693.
1992: M Bengtsson; B Simonsson; K Carlsson; B Nilsson; B Smedmyr; B Termander; Gunnar Oberg; Thomas H Tötterman
Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.
Transplantation 1992;53(4):882-8.
1991: A Björkland; R Festin; I Mendel-Hartvig; A Nyberg; L Lööf; Thomas H Tötterman
Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells.
Hepatology (Baltimore, Md.) 1991;13(6):1106-11.
1991: A Björkland; I Mendel-Hartvig; B Dean Nelson; Thomas H Tötterman
Primary biliary cirrhosis (PBC): characterization of a monoclonal antibody (PBC-MoAb) having specificity identical with disease-associated autoantibodies.
Scandinavian journal of immunology 1991;33(6):749-53.
1991: B Smedmyr; M Bengtsson; A Jakobsson; Bengt Simonsson; Gunnar Oberg; Thomas H Tötterman
Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation.
European journal of haematology 1991;46(3):146-51.
1990: R Festin; A Björkland; Thomas H Tötterman
Single laser flow cytometric detection of lymphocytes binding three antibodies labelled with fluorescein, phycoerythrin and a novel tandem fluorochrome conjugate.
Journal of immunological methods 1990;126(1):69-78.
1990: R Gustafsson; Thomas H Tötterman; L Klareskog; Roger Hällgren
Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.
Annals of the rheumatic diseases 1990;49(1):40-5.
1989: Gunnar Tufveson; E Hanås; P G Lindgren; E Larsson; T Andersson; Bengt Fellström; J Wahlberg; Thomas H Tötterman
A review of the Uppsala experience of Biopty-Cut renal transplant biopsies.
Transplantation proceedings 1989;21(4):3581-2.
1989: M Bengtsson; J Gordon; L Flores-Romo; J A Cairns; B Smedmyr; Gunnar Oberg; B Simonsson; Thomas H Tötterman
B-cell reconstitution after autologous bone marrow transplantation: increase in serum CD23 ("IgE-binding factor") precedes IgE and B-cell regeneration.
Blood 1989;73(8):2139-44.
1989: Thomas H Tötterman; E Hanås; R Bergström; E Larsson; Gunnar Tufveson
Immunologic diagnosis of kidney rejection using FACS analysis of graft-infiltrating functional and activated T and NK cell subsets.
Transplantation 1989;47(5):817-23.
1989: Thomas H Tötterman; E Hanås; E Larsson; O Sjöberg; Gunnar Tufveson
Regulation of human allograft rejection: kidney-infiltrating suppressor inducer and suppressor effector T-cells are reduced during rejection.
Transplantation proceedings 1989;21(1 Pt 1):359-60.
1989: Thomas H Tötterman; M Höglund; M Bengtsson; Bengt Simonsson; D Almqvist; A Killander
Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects.
European journal of haematology 1989;42(2):126-33.
1989: M Bengtsson; Thomas H Tötterman; B Smedmyr; R Festin; Gunnar Oberg; Bengt Simonsson
Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis.
Leukemia 1989;3(1):68-75.
1989: E Hanås; Thomas H Tötterman; Bengt Fellström; R Bergström; Gunnar Tufveson
Circulating T-lymphocyte sub-subsets and NK-like cells in renal transplant patients: patterns associated with rejection.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1989;4(8):735-9.
1989: M Bengtsson; B Smedmyr; R Festin; Gunnar Oberg; B Simonsson; Thomas H Tötterman
B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers.
Leukemia research 1989;13(9):791-7.
1988: A Frostell; I Mendel-Hartvig; B Dean Nelson; Thomas H Tötterman; A Björkland; I C Ragan; M W Cleeter; S D Patel
Mitochondrial autoantigens in primary biliary cirrhosis. Association of disease-specific determinants with a subunit of complex I (NADH-ubiquinone reductase) of the inner mitochondrial membrane.
Scandinavian journal of immunology 1988;28(6):645-52.
1988: F Anders Karlsson; Thomas H Tötterman
Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Clinical and experimental immunology 1988;74(2):258-63.
1988: I Mendel-Hartvig; A Björkland; B Dean Nelson; R Norberg; U Ytterström; Thomas H Tötterman
Primary biliary cirrhosis: indication for a single mitochondrial antigenic epitope detected by patient autoantibodies and a novel monoclonal antibody.
Scandinavian journal of immunology 1988;28(4):403-10.
1988: Thomas H Tötterman; M Bengtsson
Treatment of pure red cell aplasia with ciclosporin: suppression of activated T suppressor/cytotoxic and NK-like cells in marrow and blood correlates with haematological response.
European journal of haematology 1988;41(3):204-11.
1988: A Frostell; I Mendel-Hartvig; B Dean Nelson; Thomas H Tötterman; A Björkland; I Ragan
Evidence that the major primary biliary cirrhosis-specific mitochondrial autoantigen is a subunit of complex I of the respiratory chain.
Scandinavian journal of immunology 1988;28(2):157-65.
1988: M Bengtsson; B Smedmyr; Bengt Simonsson; Gunnar Oberg; G Lönnerholm; Thomas H Tötterman
Repopulation of T, B, and natural killer-like cells in the blood and marrow after purged autologous bone marrow transplantation.
Transplantation proceedings 1988;20(3):506-9.
1988: Gunnar Tufveson; Thomas H Tötterman; Clas F R Källander; A Hagström; Jan Simon Gronowitz
Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation.
Transplantation proceedings 1988;20(3):405-7.
1988: Thomas H Tötterman; M Carlsson; S Funderud; B Simonsson; Gunnar Oberg; K Nilsson
Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
Nouvelle revue française d'hématologie 1988;30(5-6):279-81.
1988: Kenneth Nilsson; A Björkĺand; M Carlsson; L G Larsson; K Funa; Thomas H Tötterman
Differentiation associated c-myc expression in phorbol ester and lymphokine stimulated B-type chronic lymphocytic leukemia cells.
Current topics in microbiology and immunology 1988;141():172-80.
1988: Thomas H Tötterman; M Carlsson; K Nilsson
Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester.
Clinical and experimental immunology 1988;71(1):187-92.
1987: Thomas H Tötterman; E Hanås; E Larsson; P G Lindgren; O Sjöberg; J Wahlberg; Gunnar Tufveson
Rapid immunodiagnosis of kidney rejection by using activation markers on kidney tubular cells and infiltrating T subset cells.
Transplantation proceedings 1987;19(5):3570-1.
1987: Thomas H Tötterman; A Danersund; M Carlsson; K Nilsson
Effects of recombinant interferon-alpha and -gamma on B-CLL cells in serum-free medium: expression of activation, differentiation, and CALLA antigens.
Leukemia 1987;1(9):667-72.
1987: R Festin; B Björklund; Thomas H Tötterman
Detection of triple antibody-binding lymphocytes in standard single laser flow cytometry using colloidal gold, fluorescein and phycoerythrin as labels.
Journal of immunological methods 1987;101(1):23-8.
1987: A Karlsson-Parra; Thomas H Tötterman; A Nyberg; I Mendel-Hartvig; L Lööf; U Forsum
Immunological effects of ciclosporin in primary biliary cirrhosis: suppression of activated T cells and autoantibody levels.
International archives of allergy and applied immunology 1987;83(3):256-64.
1987: I Mendel-Hartvig; A Frostell; Thomas H Tötterman
Primary biliary cirrhosis: antigenic specificity of IgM-type mitochondrial antibodies analyzed by immunoblotting and ELISA.
International archives of allergy and applied immunology 1987;83(3):265-70.
1987: L G Larsson; H E Gray; Thomas H Tötterman; U Pettersson; Kenneth Nilsson
Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(1):223-7.
1987: Thomas H Tötterman; F A Karlsson; M Bengtsson; I Mendel-Hartvig
Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
The New England journal of medicine 1987;316(1):15-22.
1986: B Simonsson; A Danersund; Thomas H Tötterman; K Nilsson; L Wibell
Production of beta 2-microglobulin by chronic lymphocytic leukaemia cells in vitro.
Scandinavian journal of haematology 1986;36(5):424-9.
1986: Kenneth Nilsson; L G Larsson; M Carlsson; A Danersund; K Forsbeck; L Hellman; Thomas H Tötterman; U Pettersson
Expression of c-myc and c-fos during phorbol ester induced differentiation of B-type chronic lymphocytic leukemia cells.
Current topics in microbiology and immunology 1986;132():280-9.
1985: I Mendel-Hartvig; B Dean Nelson; L Lööf; Thomas H Tötterman
Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens.
Clinical and experimental immunology 1985;62(2):371-9.
1985: A Danersund; Thomas H Tötterman; K Nilsson; I Egle-Jansson; D Kabelitz; O Sjöberg
Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Clinical and experimental immunology 1985;59(3):644-52.
1985: Thomas H Tötterman; A Scheynius; A Killander; A Danersund; G V Alm
Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour mass.
Scandinavian journal of haematology 1985;34(2):196-203.
1984: Thomas H Tötterman; J Nisell; A Killander; Gösta Gahrton; B Lönnqvist
Successful treatment of pure red-cell aplasia with cyclosporin.
Lancet 1984;2(8404):693.
1984: A Karlsson-Parra; A Nyberg; Thomas H Tötterman; L Lööf; U Forsum
Primary biliary cirrhosis--phenotypic characterization of immunocompetent cells in peripheral blood and liver tissue.
Upsala journal of medical sciences 1984;89(3):254-65.
1983: Thomas H Tötterman; K Forsbeck; Kenneth Nilsson; B Simonsson; Christer Sundström; Jan Sällström
Surface glycoprotein patterns of B type chronic lymphocytic leukaemia cells correlate with the clinical activity of the disease.
Scandinavian journal of haematology 1983;30(1):79-88.
1983: Magnus Gidlund; K Nilsson; Thomas H Tötterman; H Wigzell
Natural killer cells and their targets: impact of differentiation on target cell susceptibility.
Haematology and blood transfusion 1983;28():466-9.
1982: Thomas H Tötterman; A Danersund; K Nilsson; A Killander
Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.
Blood 1982;59(5):1103-7.
1981: Kenneth Nilsson; K Forsbeck; Magnus Gidlund; Christer Sundström; Thomas H Tötterman; Jan Sällström; P Venge
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro.
Haematology and blood transfusion 1981;26():215-21.